|
| Status |
Public on Jun 23, 2019 |
| Title |
JMJD6 gene gain is a tumorigenic factor and therapeutic target in neuroblastoma |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
31346162 |
| |
| Submission date |
Apr 13, 2018 |
| Last update date |
Sep 23, 2019 |
| Contact name |
matthew kwok kei wong |
| E-mail(s) |
MWong@ccia.org.au
|
| Organization name |
Children's Cancer Institute
|
| Department |
histone modification group
|
| Street address |
Lowy cancer centre, University of New South Wales
|
| City |
Sydney |
| State/province |
New South Wales |
| ZIP/Postal code |
2031 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (13)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE112919 |
Pol2 binding examined by ChIP-seq in inducible JMJD6 knockdown neuroblastoma cells |
| GSE113139 |
H3K27ac, H3K4me and H3K4me3 binding examined by ChIP-seq in the CHP-134 neuroblastoma cell line |
| GSE129588 |
JMJD6 and NMYC binding examined by ChIP-seq in NMYC overexpressing CHP134 human neuroblastoma cells |
|
| Relations |
| BioProject |
PRJNA450133 |
Less...
More...